Proteomics approaches for the studies of bone metabolism

키워드

참고문헌 (74)

1. Ong, S. E., "Mass spectrometric- based approaches in quantitative proteomics", Methods, 29, pp.124~130 (2003)
2. Liu, N. Q., "Quantitative Proteomic Analysis of Microdissected Breast Cancer Tissues: Comparison of Label-Free and SILAC-based Quantification with Shotgun, Directed, and Targeted MS Approaches", J. Proteome. Res, 12, pp.4627~4641 (2013)
3. Shi, T., "Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics", Proteomics, 12, pp.1074~1092 (2012)
4. Chen, E. I., "Cancer proteomics by quantitative shotgun proteomics", Mol. Oncol, 1, pp.144~159 (2007)
5. Honda, K., "Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine", J. Clin. Oncol, 43, pp.103~109 (2013)
6. Cumova, J., "Proteomic analysis in multiple myeloma research", Mol. Biotechnol, 47, pp.83~93 (2011)
7. Chen, S., "Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic target", J. Cell Biochem, 114, pp.2795~2808 (2013)
8. Mertins, P., "iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics", Mol. Cell Proteomics, 11, pp.111~ (2012)
9. Blagoev, B., "A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling", Nat. Biotechnol, 21, pp.315~318 (2003)
10. Oberg, A. L., "Statistical methods for quantitative mass spectrometry proteomic experiments with labeling", BMC Bioinformatics, 13(Suppl 16), pp.S7~ (2012)
11. Ducy, P., "The osteoblast: a sophisticated fibroblast under central surveillance", Science, 289, pp.1501~1504 (2000)
12. Katagiri, T., "Regulatory mechanisms of osteoblast and osteoclast differentiation", Oral. Dis, 8, pp.147~159 (2002)
13. Boyle, W. J., "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
14. Caetano-Lopes, J., "Osteoblasts and bone formation", Acta. Reumatol. Port, 32, pp.103~110 (2007)
15. Fakhry, M., "Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts", World. J. Stem. Cells, 5, pp.136~148 (2013)
16. Kim, J. M, "Comparative secretome analysis of human bone marrow-derived mesenchymal stem cells during osteogenesis", J. Cell Physiol, 228, pp.216~224
17. Friedenstein, A. J., "Origin of bone marrow stromal mechanocytes in radiochimeras and heterotopic transplants", Exp. Hematol, 6, pp.440~444 (1978)
18. Caplan, A. I., "Mesenchymal stem cells", J. Orthop. Res, 9, pp.641~650 (1991)
19. Ghislain Moussavou, "Role of gangliosides in the differentiation of human mesenchymal-derived stem cells into osteoblasts and neuronal cells", BMB Reports, 46(11), pp.527~532 (2013), 생화학분자생물학회
20. Ding, J., "TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells", Life Sci, 84, pp.499~504 (2009)
21. Lo, T., "Phosphoproteomic analysis of human mesenchymal stromal cells during osteogenic differentiation", J. Proteome. Res, 11, pp.586~598
22. Salasznyk, R. M., "Comparing the protein expression profiles of human mesenchymal stem cells and human osteoblasts using gene ontologies", Stem. Cells Dev, 14, pp.354~366 (2005)
23. Kristensen, L. P, "Temporal profiling and pulsed SILAC labeling identify novel secreted proteins during ex vivo osteoblast differentiation of human stromal stem cells", Mol. Cell Proteomics, 11, pp.989~1007
24. Park, B. W., "In vitro and in vivo osteogenesis of human mesenchymal stem cells derived from skin, bone marrow and dental follicle tissues", Differentiation, 83, pp.249~259 (2012)
25. Tamaki, Y., "In vitro analysis of mesenchymal stem cells derived from human teeth and bone marrow", Odontology, 101, pp.121~132 (2013)
26. Patil, R., "Multilineage potential and proteomic profiling of human dental stem cells derived from a single donor", Exp. Cell Res, 320, pp.92~107 (2014)
27. Lee, J. H., "Role of PI3K on the regulation of BMP2-induced beta-Catenin activation in human bone marrow stem cells", Bone, 46, pp.1522~1532 (2010)
28. Dao-jing Xu, "Smads, p38 and ERK1", 2 are involved in BMP9-induced osteogenic differentiation of C3H10T1, BMB Reports, pp.2012, 45(4)[DOI]
29. Chen, D., "Bone morphogenetic proteins", Growth Factors, 22, pp.233~241 (2004)
30. Canalis, E., "Bone morphogenetic proteins, their antagonists, and the skeleton", Endocr Rev, 24, pp.218~235 (2003)
31. Li, X., "BMP signaling and skeletogenesis", Ann. N. Y. Acad. Sci, 1068, pp.26~40 (2006)
32. Massague, J., "TGF-beta signal transduction", Annu. Rev. Biochem, 67, pp.753~791 (1998)
33. Guicheux, J., "Activation of p38 mitogen- activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation", J. Bone. Miner. Res, 18, pp.2060~2068 (2003)
34. Ducy, P., "Osf2", Cbfa1: a transcriptional activator of osteoblast differentiation, 1997, pp.89, 747~754
35. Komori, T., "Signaling networks in RUNX2-dependent bone development", J. Cell Biochem, 112, pp.750~755 (2011)
36. Kim, B. G., "'Two-stage double-technique hybrid (TSDTH)' identification strategy for the analysis of BMP2-induced transdifferentiation of premyoblast C2C12 cells to osteoblast", J. Proteome. Res, 8, pp.4441~4454 (2009)
37. Fotia, A. B., "Regulation of neuronal voltage- gated sodium channels by the ubiquitin-protein ligases Nedd4 and Nedd4-2", J. Biol. Chem, 279, pp.28930~28935 (2004)
38. Kim, B. G, "Phospho-Smad1 modulation by nedd4 E3 ligase in BMP", TGF-beta signaling, pp.26, 1411~1424
39. Cadigan, K. M., "Wnt signaling: complexity at the surface", J. Cell Sci, 119, pp.395~402 (2006)
40. Pinzone, J. J., "The role of Dickkopf-1 in bone development, homeostasis, and disease", Blood, 113, pp.517~525 (2009)
41. Day, T. F., "Wnt", beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis, 2005, pp.8, 739~750
42. James, R. G., "Protein Kinase PKN1 represses Wnt", beta-catenin signaling in human melanoma cells, 2013, pp.288, 34658~34670
43. Silverio, K. G., "Wnt", beta-catenin pathway regulates bone morphogenetic protein(BMP2)-mediated differentiation of dental follicle cells. J. Periodontal. Res, 2012, pp.47, 309~319
44. Zhang, R., "Wnt", beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts, 2013, pp.52, 145~156
45. Suda, T., "Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families", Endocr. Rev, 20, pp.345~357 (1999)
46. Takahashi, N., "A new member of tumor necrosis factor ligand family, ODF", OPGL, RANKL, regulates osteoclast differentiation and function, pp.Biochem. Biophys. Res. Commun, 1999[DOI]
47. Teitelbaum, S. L., "Bone resorption by osteoclasts", Science, 289, pp.1504~1508 (2000)
48. Gori, F., "The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated", Endocrinology, 141, pp.4768~4776 (2000)
49. Krane, S. M., "Identifying genes that regulate bone remodeling as potential therapeutic targets", J. Exp. Med, 201, pp.841~843 (2005)
50. Kim, H. H., "RANKL regulates endothelial cell survival through the phosphatidylinositol 3'-kinase", Akt signal transduction pathway, 2003, pp.17, 2163~2165
51. Lamghari, M., "Leptin effect on RANKL and OPG expression in MC3T3-E1 osteoblasts", J. Cell. Biochem, 98, pp.1123~1129 (2006)
52. Anderson, D. M., "A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function", Nature, 390, pp.175~179 (1997)
53. Lacey, D. L., "Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation", Cell, 93, pp.165~176 (1998)
54. Yasuda, H., "Osteoclast differentiation factor is a ligand for osteoprotegerin", osteoclastogenesis-inhibitory factor and is identical to TRANCE, Proc. Natl. Acad. Sci. U. S. A, pp.1998, 95[DOI]
55. Kubota, K., "PDGF BB purified from osteoclasts acts as osteoblastogenesis inhibitory factor (OBIF)", J. Biomol. Tech, 13, pp.62~71 (2002)
56. Kubota, K., "Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor", J. Bone. Miner. Res, 17, pp.257~265 (2002)
57. Kubota, K., "Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: two-dimensional electrophoresis and isotope-coded affinity tags analysis with two-dimensional chromatography", Proteomics, 3, pp.616~626 (2003)
58. Baum, J, "Folding of peptide models of collagen and misfolding in disease", Curr. Opin. Struct. Biol, 9, pp.122~128 (1999)
59. Fantner, G. E., "Influence of the degradation of the organic matrix on the microscopic fracture behavior of trabecular bone", Bone, 35, pp.1013~1022 (2004)
60. Xiao, Z., "Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts", J. Cell Physiol, 210, pp.325~335 (2007)
61. Balcerzak, M., "Proteome analysis of matrix vesicles isolated from femurs of chicken embryo", Proteomics, 8, pp.192~205 (2008)
62. Wu, L. N., "Association between proteoglycans and matrix vesicles in the extracellular matrix of growth plate cartilage", J. Biol. Chem, 266, pp.1187~1194 (1991)
63. Kirsch, T., "The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage", J. Biol. Chem, 275, pp.35577~35583 (2000)
64. Kassem, M., "Osteoblastic cells: differentiation and trans-differentiation", Arch. Biochem. Biophys, 473, pp.183~187 (2008)
65. Choi, Y. A., "Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation", J. Proteome. Res, 9, pp.2946~2956 (2010)
66. Rainger, J, "Loss of the BMP antagonist, SMOC-1, causes Ophthalmo-acromelic (Waardenburg Anophthalmia) syndrome in humans and mice", PLoS Genet, 7, pp.e1002114~ (2011)
67. Bjornaes, I., "Transvascular and interstitial transport of a 19 kDa linear molecule in human melanoma xenografts measured by contrast-enhanced magnetic resonance imaging", J. Magn. Reson. Imaging, 14, pp.608~616 (2001)
68. Martinek, N., "Is SPARC an evolutionarily conserved collagen chaperone?", J. Dent. Res, 86, pp.296~305 (2007)
69. Kim, J. M., "Comparative secretome analysis of human bone marrow-derived mesenchymal stem cells during osteogenesis", J. Cell Physiol, 228, pp.216~224 (2013)
70. Alves, R. D., "Activin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production", Mol. Cell Proteomics, 12, pp.2890~2900 (2013)
71. Thouverey, C., "Proteomic characterization of biogenesis and functions of matrix vesicles released from mineralizing human osteoblast- like cells", J. Proteomics, 74, pp.1123~1134 (2011)
72. Li, J., "An integrated proteomics analysis of bone tissues in response to mechanical stimulation", BMC. Syst. Biol, 5(Suppl 3), pp.S7~ (2011)
73. Kim, H. K., "The correlation of Salvia miltiorrhiza extract- induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone. Immunopharmacol", Immunotoxicol, 30, pp.347~364 (2008)
74. Yokozawa, T., "Confirmation that magnesium lithospermate B has a hydroxyl radical-scavenging action", Exp. Toxicol. Pathol, 47, pp.341~344 (1995)

관련 논문AI추천